Parnell Pharmaceuticals Holdings Ltd Company Profile (NASDAQ:PARN)

About Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)

Parnell Pharmaceuticals Holdings Ltd logoParnell Pharmaceuticals Holdings Limited is a veterinary pharmaceutical company. The Company is focused on developing, manufacturing and commercializing animal health solutions. The principal activities of the Company include manufacture for global sale of animal pharmaceutical product, and research and development of pharmaceutical products for global animal health markets. The Company operates through four segments: Companion Animal, Production Animal-U.S., Production Animal-Rest of World and Manufacturing Operations. It augments its pharmaceutical products with its FETCH and mySYNCH software platforms. It offers disease-modifying product, Zydax, for the treatment of osteoarthritis (OA). Its reproductive hormone products include estroPLAN and GONAbreed. It has a nutraceutical product, Glyde. It also markets a non-steroidal anti-inflammatory drug (NSAID), called Tergive. It is developing a pipeline of clinical drug candidates, such as PAR 121, PAR 122, PAR 101, PAR 081 and PAR 061.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Symbol: NASDAQ:PARN
  • CUSIP: N/A
  • Web: www.parnell.com
Average Prices:
  • 50 Day Moving Avg: $1.03
  • 200 Day Moving Avg: $1.38
  • 52 Week Range: $0.65 - $3.95
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.21
  • P/E Growth: 0.0000
Debt:
  • Debt-to-Equity Ratio: 0.82%
  • Current Ratio: 0.61%
  • Quick Ratio: 0.37%
Misc:
  • Average Volume: 85,051 shs.
  • Beta: 0.14
 

Frequently Asked Questions for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)

What is Parnell Pharmaceuticals Holdings Ltd's stock symbol?

Parnell Pharmaceuticals Holdings Ltd trades on the NASDAQ under the ticker symbol "PARN."

Who are some of Parnell Pharmaceuticals Holdings Ltd's key competitors?

Who owns Parnell Pharmaceuticals Holdings Ltd stock?

Parnell Pharmaceuticals Holdings Ltd's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Sabby Management LLC (0.00%). View Institutional Ownership Trends for Parnell Pharmaceuticals Holdings Ltd.

Who bought Parnell Pharmaceuticals Holdings Ltd stock? Who is buying Parnell Pharmaceuticals Holdings Ltd stock?

Parnell Pharmaceuticals Holdings Ltd's stock was bought by a variety of institutional investors in the last quarter, including Sabby Management LLC. View Insider Buying and Selling for Parnell Pharmaceuticals Holdings Ltd.

How do I buy Parnell Pharmaceuticals Holdings Ltd stock?

Shares of Parnell Pharmaceuticals Holdings Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Parnell Pharmaceuticals Holdings Ltd stock cost?

One share of Parnell Pharmaceuticals Holdings Ltd stock can currently be purchased for approximately $0.69.

Analyst Ratings

Consensus Ratings for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/24/2016Dawson JamesReiterated RatingBuyN/AView Rating Details
4/1/2016Jefferies Group LLCReiterated RatingBuy$18.00 -> $16.00N/AView Rating Details
2/29/2016Piper Jaffray CompaniesReiterated RatingOverweight$12.00 -> $9.00N/AView Rating Details
(Data available from 5/24/2015 forward)

Earnings

Earnings History for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
Earnings by Quarter for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
Earnings History by Quarter for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/21/2015Q3($0.22)($0.13)ViewListenView Earnings Details
8/11/2015Q2($0.26)($0.19)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
Current Year EPS Consensus Estimate: $-1.5200 EPS
Next Year EPS Consensus Estimate: $-0.5700 EPS

Dividends

Dividend History for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
Latest Headlines for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
Source:
DateHeadline
feeds.benzinga.com logoParnell to Report Business Update for the Three Months Ended March 31, 2017 on May 24, 2017
feeds.benzinga.com - May 19 at 12:49 AM
finance.yahoo.com logoEdited Transcript of PARN earnings conference call or presentation 21-Mar-17 9:00pm GMT
finance.yahoo.com - March 22 at 7:05 PM
biz.yahoo.com logoQ4 2016 Parnell Pharmaceuticals Holdings Ltd Earnings Release - 4:00 pm ET
biz.yahoo.com - March 21 at 11:08 AM
globenewswire.com logoParnell to Report Financial Results for Fiscal Year 2016 on March 22, 2017 - GlobeNewswire (press release)
globenewswire.com - February 23 at 7:13 PM
streetinsider.com logoForm 25 Parnell Pharmaceuticals - StreetInsider.com - StreetInsider.com
www.streetinsider.com - December 22 at 12:59 AM
streetinsider.com logoParnell Pharmaceuticals (PARN) Files to Voluntarily Delist from NASDAQ
www.streetinsider.com - December 20 at 6:33 PM
globenewswire.com logoParnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQ - GlobeNewswire (press release)
globenewswire.com - December 20 at 1:31 PM
finance.yahoo.com logoPARN: Voluntarily Moving From the Nasdaq to the OTC…
finance.yahoo.com - December 15 at 8:07 PM
feeds.benzinga.com logo15 Biggest Mid-Day Losers For Monday
feeds.benzinga.com - December 12 at 2:38 PM
us.rd.yahoo.com logo3:02 am Parnell Pharmaceuticals intends to move from the NASDAQ OMX Global Market; expects to move to the OTC Pink open market
us.rd.yahoo.com - December 12 at 9:49 AM
globenewswire.com logoParnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and ... - GlobeNewswire (press release)
globenewswire.com - December 9 at 7:05 PM
globenewswire.com logoParnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility - GlobeNewswire (press release)
globenewswire.com - November 24 at 9:57 AM
finance.yahoo.com logo3:16 am Parnell Pharmaceuticals receives $20 million, senior secured, non-dilutive, term loan agreement with SWK Holdings
finance.yahoo.com - November 23 at 9:56 AM

Social

Chart

Parnell Pharmaceuticals Holdings Ltd (PARN) Chart for Wednesday, May, 24, 2017

This page was last updated on 5/24/2017 by MarketBeat.com Staff